Op-Eds
I helped negotiate Trump’s trade deal. He can now fix what Pelosi broke
Andrei Iancu
November 28, 2025
Lawmakers must reject I-MAK’s questionable data and abandon two damaging bills, the Drug Competition Enhancement Act and Affordable Prescriptions for Patients Act.
Congress should base patent policy on evidence, not accusations
Frank Cullen
October 11, 2025
Lawmakers must reject I-MAK’s questionable data and abandon two damaging bills, the Drug Competition Enhancement Act and Affordable Prescriptions for Patients Act.




